Proxy advisory firm InGovern has warned that the reasoning behind the Delhi High Court’s order for a forensic audit of Fortis Healthcare could have wider consequences for listed companies if it is upheld. InGovern said the order could expose listed companies to enforcement proceedings linked to the personal liabilities of their promoters, even when the company itself was not a party to the original dispute.
The concern arises from proceedings related to the enforcement of a Singapore arbitration award that Daiichi Sankyo holds against the Singh brothers, the former promoters of Fortis, in their personal capacity. The forensic audit was ordered on August 31, 2026. The matter is next listed on April 1, 2027.
